(Q40658398)

22 September 2017

1 reference

title

Does corticosteroid pretreatment enhance the effect of alfa interferon treatment in chronic hepatitis B? (English)

1 reference

22 September 2017

Krogsgaard K

1

1 reference

22 September 2017

1 February 1994

1 reference

22 September 2017

Journal of Hepatology

1 reference

22 September 2017

20

1 reference

22 September 2017

2

1 reference

22 September 2017

159-162

1 reference

Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Treatment of chronic hepatitis B in children with prednisone followed by alfa-interferon: a controlled randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Beneficial effect of prednisolone withdrawal followed by human lymphoblastoid interferon on the treatment of chronic type B hepatitis in Asians: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Efficacy of steroid withdrawal and low-dose interferon treatment in chronic active hepatitis B. Results of a randomized multicenter trial. Swiss Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Rapid withdrawal of immunosuppressive therapy in chronic active hepatitis B infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Effects of prednisolone/azathioprine in chronic hepatitis B viral infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Prednisone withdrawal followed by recombinant alpha interferon in the treatment of chronic type B hepatitis. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Efficacy of interferon alfa-2b with or without prednisone withdrawal in the treatment of chronic viral hepatitis B. A prospective double-blind Belgian-Dutch study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

Glucocorticoid stimulates hepatitis B viral gene expression in cultured human hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2805%2980052-2

7 January 2021

10.1016/S0168-8278(05)80052-2

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

8006394